肿瘤标志物的临床应用建议

被引：89

作者：

沈立松

周韵斓

尚红

潘柏申

机构：

[1] 中华医学会检验分会

[2] 卫生部临床检验中心

[3] 中华检验医学杂志编辑委员会

来源：

中华检验医学杂志 | 2012年 / 02期

关键词：

D O I：

暂无

中图分类号：

R730.4 [肿瘤诊断学];

学科分类号：

100214 ;

摘要：

<正>肿瘤的发病率逐年升高,且发病年龄有年轻化的趋势,恶性肿瘤的早期诊断及定位相对困难,死亡率高,严重危害人类健康。现在肿瘤和心脑血管疾病,成为发病率和死亡率最高的两类疾病。为了科学、合理地将肿瘤标志物(tumor marker,TM)应用于肿瘤的筛查、诊断、预后评估、疗效监测、复发预测等环节,中华医学会检验分会、卫生部临床检验中心和中华检验医学杂志编辑委员会共同制定TM的临床应用建议。本建议在制定过程中,主要参考了美国临床生化学会(National Academy of Clinical

引用

页码：103 / 116

共 29 条

[1] 肿瘤标志物临床检测的基本原则(建议稿)附视频 [J].

陈允硕 ;

吴健民 .

中华检验医学杂志, 2004, (06) :60-60

[2] Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC [J].

Toyoda, Hidenori ;

Kumada, Takashi ;

Kaneoka, Yuji ;

Osaki, Yukio ;

Kimura, Toru ;

Arimoto, Akira ;

Oka, Hiroko ;

Yamazaki, Osamu ;

Manabe, Takao ;

Urano, Fumihiro ;

Chung, Hobyung ;

Kudo, Masatoshi ;

Matsunaga, Takashi .

JOURNAL OF HEPATOLOGY, 2008, 49 (02) :223-232

[3]

Improving the comparability of immunoassays for prostate-specific antigen (PSA): Progress and problems[J] . Catharine M. Sturgeon,Andrew R. Ellis.Clinica Chimica Acta . 2007 (1)

[4] Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden [J].

Bruun, L ;

Becker, C ;

Hugosson, J ;

Lilja, H ;

Christensson, A .

PROSTATE, 2005, 65 (03) :216-221

[5]

The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention[J] . Barry J. Marshall,Helen M. Windsor.Medical Clinics of North America . 2005 (2)

[6] Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer [J].

Goldstein, MJ ;

Mitchell, EP .

CANCER INVESTIGATION, 2005, 23 (04) :338-351

[7]

Colon Cancer Screening Guidelines 2005: The Fecal Occult Blood Test Option Has Become a Better FIT[J] . James E. Allison.Gastroenterology . 2005 (2)

[8]

Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening[J] . Journal of Medical Screening . 2004 (3)

[9] Diagnosis and staging of hepatocellular carcinoma [J].

Talwalkar, JA ;

Gores, GJ .

GASTROENTEROLOGY, 2004, 127 (05) :S126-S132

[10]

Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines[J] . Joseph Watine,Bruno Friedberg.Clinica Chimica Acta . 2004 (1)

← 1 2 3 →